Quantifying drug primary mechanism of action parameter in HIV (viral) dynamics

Abstract

Surface thermodynamics concept was used to quantify drug primary mechanism of action parameter in control infectivity of viral dynamics. The methodology involved expressing interfacial energetics of Hamaker constant, a thermodynamic tool capable of being optimized for disease extinction as drug primary mechanism of action parameter in control infectivity of viral dynamics. The expressed drug primary mechanism of action parameter and the associated drug primary mechanism of action are quantified from imported Hamaker constants data of experimental drugs.